BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

M Xing - Endocrine reviews, 2007 - academic.oup.com
In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

M Xing - Endocrine reviews, 2007 - pubmed.ncbi.nlm.nih.gov
In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …

[引用][C] BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

M XING - Endocrine reviews, 2007 - pascal-francis.inist.fr
BRAF Mutation in Papillary Thyroid Cancer : Pathogenic Role, Molecular Bases, and
Clinical Implications CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[引用][C] BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

M Xing - Endocrine Reviews, 2007 - cir.nii.ac.jp
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical
Implications | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.

M Xing - Endocrine Reviews, 2007 - europepmc.org
In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …

BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications

M Xing - Endocrine Reviews, 2007 - pure.johnshopkins.edu
In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …